RO
Laboratorios Farmaceuticos Rovi, S.A.
ROVI.MC · BME
59.15 € -0.67% (-0.40 €)
1M +1.19%
Market Cap 3.04B €
P/E Ratio 16.42x
Div. Yield 1.61%
ROE 27.84%
Bulios Fair Price
45.76 €
22.6% downside
Trenutna cena
59.15 €
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ROVI.MC trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
60 /100
Fair P/FCF 17.20x
P/S 3.93x
P/B 4.34x
Growth
9 /100
Declining Rev. growth 3.12%
FCF growth 13.59%
Book val. growth 8.51%
Profitability
97 /100
Strong Net margin 23.95%
Op. margin 21.97%
FCF margin 22.87%
Quality
86 /100
Excellent ROE 27.84%
ROA 16.43%
Asset turnover 0.69x
Debt
100 /100
Low Current ratio 2.05x
Int. coverage 54.42x
Net debt/EBITDA -0.07x
Stability
77 /100
Stable Rev. volatility 4.70%
EPS volatility 11.15%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ROVI.MC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Juan Lopez-Belmonte Encina
Employees
2,470
Headquarters
Pozuelo de Alarcón
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report